| Vascular smooth muscle contraction in hypertension RM Touyz, R Alves-Lopes, FJ Rios, LL Camargo, A Anagnostopoulou, ... Cardiovascular research 114 (4), 529-539, 2018 | 546 | 2018 |
| Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications A Harvey, AC Montezano, RA Lopes, F Rios, RM Touyz Canadian Journal of Cardiology 32 (5), 659-668, 2016 | 419 | 2016 |
| Angiotensin II and vascular injury AC Montezano, A Nguyen Dinh Cat, FJ Rios, RM Touyz Current hypertension reports 16, 1-11, 2014 | 397 | 2014 |
| Acute toxicity of anionic and non-ionic surfactants to aquatic organisms M Lechuga, M Fernández-Serrano, E Jurado, J Núñez-Olea, F Ríos Ecotoxicology and environmental safety 125, 1-8, 2016 | 281 | 2016 |
| Oxidative stress and hypertension KK Griendling, LL Camargo, FJ Rios, R Alves-Lopes, AC Montezano, ... Circulation research 128 (7), 993-1020, 2021 | 246 | 2021 |
| Oxidative stress: a unifying paradigm in hypertension RM Touyz, FJ Rios, R Alves-Lopes, KB Neves, LL Camargo, ... Canadian journal of cardiology 36 (5), 659-670, 2020 | 218 | 2020 |
| Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome HY Small, AC Montezano, FJ Rios, C Savoia, RM Touyz Canadian Journal of Cardiology 30 (5), 534-543, 2014 | 138 | 2014 |
| TRPM7, magnesium, and signaling ZG Zou, FJ Rios, AC Montezano, RM Touyz International journal of molecular sciences 20 (8), 1877, 2019 | 124 | 2019 |
| Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis DS Skiba, R Nosalski, TP Mikolajczyk, M Siedlinski, FJ Rios, ... British Journal of Pharmacology 174 (22), 4055-4069, 2017 | 118 | 2017 |
| Vascular Nox (NADPH oxidase) compartmentalization, protein hyperoxidation, and endoplasmic reticulum stress response in hypertension LL Camargo, AP Harvey, FJ Rios, S Tsiropoulou, RNO Da Silva, Z Cao, ... Hypertension 72 (1), 235-246, 2018 | 106 | 2018 |
| Chemerin regulates crosstalk between adipocytes and vascular cells through Nox KB Neves, A Nguyen Dinh Cat, RAM Lopes, FJ Rios, A Anagnostopoulou, ... Hypertension 66 (3), 657-666, 2015 | 102 | 2015 |
| NOX5: molecular biology and pathophysiology RM Touyz, A Anagnostopoulou, F Rios, AC Montezano, LL Camargo Experimental physiology 104 (5), 605-616, 2019 | 96 | 2019 |
| VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes KB Neves, FJ Rios, L Van Der Mey, R Alves-Lopes, AC Cameron, ... Hypertension 71 (4), 638-647, 2018 | 95 | 2018 |
| Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis FJ Rios, ZG Zou, AP Harvey, KY Harvey, R Nosalski, P Anyfanti, ... Cardiovascular research 116 (3), 721-735, 2020 | 93 | 2020 |
| Acute effects of electronic and tobacco cigarettes on vascular and respiratory function in healthy volunteers: a cross-over study DMI Kerr, KJM Brooksbank, RG Taylor, K Pinel, FJ Rios, RM Touyz, ... Journal of hypertension 37 (1), 154-166, 2019 | 81 | 2019 |
| Vascular biology of superoxide-generating NADPH oxidase 5—implications in hypertension and cardiovascular disease RM Touyz, A Anagnostopoulou, LL Camargo, FJ Rios, AC Montezano Antioxidants & Redox Signaling 30 (7), 1027-1040, 2019 | 80 | 2019 |
| Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR FJ Rios, MM Koga, M Pecenin, M Ferracini, M Gidlund, S Jancar Mediators of inflammation 2013, 2013 | 79 | 2013 |
| Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor M Ferracini, FJO Rios, M Pecenin, S Jancar Mediators of inflammation 2013, 2013 | 78 | 2013 |
| Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts FJO Rios, M Ferracini, M Pecenin, MM Koga, Y Wang, DFJ Ketelhuth, ... Plos one 8 (10), e76893, 2013 | 69 | 2013 |
| Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses DFJ Ketelhuth, FJO Rios, Y Wang, H Liu, ME Johansson, GN Fredrikson, ... Circulation 124 (22), 2433-2443, 2011 | 63 | 2011 |
